Filing Details
- Accession Number:
- 0001062993-22-022722
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-23 16:10:24
- Reporting Period:
- 2022-11-22
- Accepted Time:
- 2022-11-23 16:10:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1603454 | Celcuity Inc. | CELC | Services-Medical Laboratories (8071) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1829248 | A. Polly Murphy | 16305 36Th Avenue N. Suite 100 Minneapolis MN 55446 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-22 | 5,000 | $9.68 | 5,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $8.31 | 2032-09-12 | 10,000 | 10,000 | Direct | |
Common Stock | Stock Option (right to buy) | $8.31 | 2032-09-12 | 16,300 | 16,300 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2032-09-12 | 10,000 | 10,000 | Direct |
2032-09-12 | 16,300 | 16,300 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.6500 to $9.7000 inclusive. The reporting person undertakes to provide Celcuity Inc., any security holder of Celcuity Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- 2,500 shares vest on each of 9/12/23, 9/12/24, 9/12/25 and 9/12/26.
- This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.